Milestone Scientific Inc. Publishes Video Interview with Dr. Ayman A. Alian, Division Chief of Obstetric & Gynecological Anes...
October 22 2020 - 9:00AM
Milestone Scientific Inc. (NYSE
American:MLSS), a leading
developer of computerized drug delivery instruments that provides
virtually painless and precise injections, reports it has published
a video interview with Dr. Ayman A. Alian, MBChB, Associate
Professor of Anesthesiology and Division Chief of Obstetric &
Gynecological Anesthesiology at the Yale School of Medicine.
The interview, which highlights the advantages of the CompuFlo®
Epidural System and CathCheck™, is available at:
https://www.milestonescientific.com/news-media/presentations
Dr. Alian discusses the benefits of the CompuFlo® Epidural
System and CathCheck™, including verification of epidural placement
during an epidural procedure and confirmation of catheter
placement. Dr. Alian states, “It does improve the block. It does
help you make a decision. It does decrease complications. It does
decrease length of stay and improve patient satisfaction.”
Arjan Haverhals, President of Milestone Scientific and CEO of
Wand Dental Inc., commented, “We are grateful to Dr. Alian for his
leadership in adopting the CompuFlo® Epidural System and CathCheck™
as part of his practice. We believe the support from Dr. Alian and
other anesthesiologists is further validation of our technology and
advances us towards our goal of CompuFlo® and CathCheck™ becoming
the new standard of care.”
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS) is a biomedical
technology research and development company that patents, designs
and develops innovative diagnostic and therapeutic injection
technologies and instruments for medical, dental, cosmetic and
veterinary applications. Milestone's computer-controlled systems
are designed to make injections precise, efficient, and virtually
painless. Milestone’s proprietary DPS Dynamic Pressure Sensing
technology® is our technology platform that advances the
development of next-generation devices, regulating flow rate and
monitoring pressure from the tip of the needle, through platform
extensions for local anesthesia for subcutaneous drug delivery,
with specific applications for cosmetic botulinum toxin injections,
epidural space identification in regional anesthesia procedures and
intra-articular joint injections. For more information please visit
our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2019. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact:David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024